Ian F. Smith
2014
In 2014, Ian F. Smith earned a total compensation of $15.3M as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals, a 266% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $731,250 |
|---|---|
| Option Awards | $4,044,646 |
| Salary | $650,000 |
| Stock Awards | $9,865,110 |
| Other | $12,857 |
| Total | $15,303,863 |
Smith received $9.9M in stock awards, accounting for 64% of the total pay in 2014.
Smith also received $731.3K in non-equity incentive plan, $4M in option awards, $650K in salary and $12.9K in other compensation.
Rankings
In 2014, Ian F. Smith's compensation ranked 218th out of 13,032 executives tracked by ExecPay. In other words, Smith earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 218 out of 13,032 | 98th |
Division Manufacturing | 80 out of 4,967 | 98th |
Major group Chemicals And Allied Products | 31 out of 1,690 | 98th |
Industry group Drugs | 26 out of 1,369 | 98th |
Industry Pharmaceutical Preparations | 24 out of 1,042 | 98th |
Source: SEC filing on April 28, 2017.
Smith's colleagues
We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2014.